TrialAmerican journal of respiratory and critical care medicine2019

IL-1 Blockade Reduces Inflammation in Pulmonary Arterial Hypertension and Right Ventricular Failure: A Single-Arm, Open-Label, Phase IB/II Pilot Study.

Cory R Trankle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.